Skip to main content
Moogene Medi Co., Ltd. logo

Moogene Medi Co., Ltd. — Investor Relations & Filings

Ticker · 322970 ISIN · KR7322970005 KO Manufacturing
Open in API
Filings indexed 183 across all filing types
Latest filing 2026-04-02 Capital/Financing Update
Country KR South Korea
Listing KO 322970

About Moogene Medi Co., Ltd.

http://moogene.com/eng/

Moogene Medi Co., Ltd. is a biotechnology company specializing in nanomedicine and the development of advanced drug delivery systems. The company focuses on its proprietary Lipid Nanoparticle (LNP) carrier system and other nano-bio technologies to safely and effectively transport a range of therapeutic agents, including genes, chemicals, and proteins. Its primary mission is to create novel therapeutics for severe and incurable diseases. The development pipeline includes gene therapies for conditions such as cancer, metabolic diseases, and androgenic alopecia, utilizing technologies like CRISPR/Cas9 gene editing. Moogene Medi operates an aseptic, GMP-grade facility, providing end-to-end support from initial research to GMP-scale production for clinical studies.

Recent filings

Filing Released Lang Actions
[기재정정]증권발행결과(자율공시)
Capital/Financing Update Classification · 88% confidence The document is a public announcement of the results of a securities issuance (a private placement of convertible bonds), including issuance amount, dates, and related corrections. This clearly relates to fundraising/financing activities and capital structure changes rather than a simple regulatory filing or report publication. Therefore it falls under Capital/Financing Update (CAP).
2026-04-02 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 85% confidence The document is a Korean ‘주요사항보고서(전환사채권 발행결정)’ which details the decision to issue convertible bonds (amount, terms, conversion mechanics, early redemption, collateral, use of proceeds, etc.) and even includes a correction to the originally filed report. It is a regulatory disclosure related to the company’s fundraising and financing activity. This aligns with our “Capital/Financing Update” category.
2026-04-02 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 97% confidence The document is the formal results of the company’s Annual General Meeting, listing voting outcomes on financial statements, director appointments, and other shareholder resolutions. This precisely matches a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-03-31 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 90% confidence The document is a self‐disclosure in Korean titled “증권 발행결과 (자율공시),” detailing the results of a securities issuance (type of security, issuance method via third‐party allotment, number of shares, issuance amount, board resolution date, payment date, listing status, etc.). This clearly falls under “Share Issue/Capital Change” announcements for new share issues. Hence, it should be classified as Code SHA.
2026-03-26 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 90% confidence The document is a corporate disclosure of the results of a securities issuance (convertible bonds), detailing issuance amount, dates, and listing status. This is an update on the company's financing activity (fundraising through debt issuance). Therefore it falls under Capital/Financing Update (CAP).
2026-03-26 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) and contains detailed corporate information, including company history, capital structure, shareholding details, and management information for the 10th fiscal year (2025). In the Korean regulatory context, the '사업보고서' is the equivalent of the US 10-K Annual Report, providing comprehensive financial and operational disclosures. It is not an announcement or a summary, but the full report itself. FY 2025
2026-03-23 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.